IP Bio/Physico-chemical Assay IHC RT-PCR IHC Biological Activity In Vivo Animal Model:8 weeks, 200-250 g male adult Wistar rats [1] Dosage:5 mg/kg Administration:I.p
Ready to explore quality peptide options
For many, Tirzepatide represented the peak of pharmaceutical intervention
We want to make sure you're informed about an upcoming change to insurance coverage that may affect some patients currently taking GLP-1 medications, including Ozempic, Wegovy, Mounjaro, and Zepbound
doi:10.1001/jama.2023.19574
Have insurance that covers brand-name GLP-1s: If your insurance plan covers Wegovy or Zepbound for weight management with reasonable copays, obtaining the FDA-approved medications through your regular healthcare provider and local pharmacy may be preferable to paying out-of-pocket for compounded versions